Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study

BACKGROUND: Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. OBJECTIVE: This study aimed to describe the long‐term outcomes in a large cohort of patients on golimumab who had ulcerative col...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:United European Gastroenterol J
Hoofdauteurs: Pugliese, Daniela, Privitera, Giuseppe, Rogai, Francesca, Variola, Angela, Viola, Anna, Laterza, Lucrezia, Privitera, Antonino C., Allocca, Mariangela, Bossa, Fabrizio, Cappello, Maria, Daperno, Marco, Lorenzon, Greta, Mazzuoli, Silvia, Principi, Mariabeatrice, Sablich, Renato, Moser, Luisa, Ferronato, Antonio, Traini, Sara, Tapete, Gherardo, Bodini, Giorgia, Di Girolamo, Maria, Grossi, Laurino, Mocci, Giammarco, Ricci, Chiara, Saibeni, Simone, Festa, Stefano, Spagnuolo, Rocco, Cortelezzi, Claudio C., Mocciaro, Filippo, Rizzello, Fernando, Armuzzi, Alessandro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2021
Onderwerpen:
Inflammatory Bowel Disease
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259241/
https://ncbi.nlm.nih.gov/pubmed/33203342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620974308
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items